Aktiesnakken — August 2010
-
så flere aftaler og licenser
-
genmab kan ikke løbe tør for cash nu selv hvis de ikke sælger fabrikken
-
nej solsen, salget er godt
-
sådan ser et uptake altså ud!
-
iøvrigt kan du se på volumen at det primært er private der sælger
-
efter 2 kvartaler har du et salg der dækker 10% af dine udgifter, det er en case der har forandret sig
-
præcis solsen! og det budskab kommer en ny ceo IKKE med og skuffer
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind